The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Assessed listed medicines (25)
- Advertising (248)
- Medicine safety (158)
- COVID-19 (144)
- Prescription medicines (136)
- Regulatory compliance (124)
- COVID-19 vaccines (88)
- Legislation (81)
- Therapeutic goods regulation (72)
- Listed medicines (52)
- Safety (49)
- Non-prescription medicines (48)
- Medical devices safety (43)
- Vaping hub (39)
- Complementary medicines (32)
- Manufacturing (31)
- Labelling and packaging (28)
- Over the counter (OTC) medicines (24)
- Scheduling (national classification system) (24)
- Compliance and enforcement hub (22)
- Australian Register of Therapeutic Goods (ARTG) (20)
- Medicinal cannabis hub (20)
- Import and export (19)
- Alert/Advisory (17)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (8)
- Weight loss products (6)
- Advisory bodies and committees (5)
- Clinical trials (3)
- Cosmetics (3)
- Blood and blood components (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Registered complementary medicines (2)
- Unique Device Identification (UDI) hub (2)
- Advanced therapies (1)
- Blood safety (1)
- Breast implant hub (1)
- Travelling with health products (1)
Search
25 result(s) found, displaying 1 to 25
-
NoticesListed medicines indications and requirements for their use have been updated in the Therapeutic Goods (Permissible Indications) Determination (No. 1) 2025.
-
NewsThe Assessed listed medicine evidence guidelines have been updated, based on feedback, to aid sponsors in preparing their product applications.
-
NoticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2023.
-
NewsNew guidelines and mandatory requirements for listed medicines ingredients have come into effect on 1 February 2023.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 5) 2022.
-
NewsThe Pharmacovigilance Inspection Program (PVIP) Risk Assessment Survey is now open until 18 December 2022 for medicine sponsors to complete.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2022.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2022.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commences on 1 March 2022.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commenced on 18 January 2022.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commenced on 25 October 2021.
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
NoticesThe Therapeutic Goods (Permissible Indications) Determination has been updated
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
Media releasesToday the TGA announced a final decision to down-schedule certain low dose cannabidiol (CBD) preparations
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
BlogHow to find information about the inactive ingredients in your medicines.
-
NoticesListed medicine ingredients and requirements have been updated.
-
NoticesThe Permissible Ingredients Determination has been updated.
-
NoticesThe Permissible Ingredients Determination has been updated.
-
NoticesThe Therapeutic Goods (Permissible Indications) Determination has been updated
-
NoticesAn amendment to the Therapeutic Goods (Permissible Ingredients) Determination commenced on 2 September 2019.
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.